- The NIH has awarded approximately $470 million to researchers who are fighting COVID-19. study the long-term effects of
- The award goes to NYU Langone Medical Center, which will serve as the central center for long-term COVID research and provide smaller grants to other scientists.
- Long covid is a condition in which patients suffer from symptoms for weeks or months after their coronavirus infection
- This represents almost 40% of the $1.15 billion allocated by Congress for longer COVID research in the $470 million US rescue plan
National Institutes of Health (NIH) Nearly $470 million awarded For researchers who will study the long-term effects of COVID-19 among thousands of patients.
The grant will go to the New York University (NYU) Langone Medical Center, which will serve as the central center for long-term COVID research and provide smaller grants to more than 100 scientists.
The $470 million in the US rescue plan represents nearly 40 percent of the $1.15 billion allocated by Congress for longer COVID research.
NIH Director Dr. Francis Collins says the award is a big step forward for the thousands of long-term COVID patients in the US, many of whom have ‘completely lost their lives affected by the major long-term effects of COVID-19. has done.’
Symptoms of COVID can last long after an initial infection – or initial visit to the hospital – for many patients who develop COVID for a long time. A new research grant will enable scientists to find out why. Image: A COVID patient in the ICU at a Boise, Idaho hospital, August 2021
NIH Director Dr Francis Collins said the long-term COVID research funding is a big step forward for patients who have ‘totally impacted their lives’ by the virus. Pictured: Collins holds a coronavirus model as she testifies on Capitol Hill in May 2021
In February 2021, the NIH announced a new initiative to study protracted covid, a condition in which patients have prolonged symptoms for weeks or months after their coronavirus infection.
In Symptoms may include Neurological issues like fatigue and brain fog, shortness of breath, chronic cough, anxiety and depression, gastrointestinal issues and many more.
According to NIH estimates, 10 to 30 percent of people infected with the corona virus will have symptoms for a long time.
Some long-lived COVID patients, who originally contracted the virus in spring 2020, are still experiencing symptoms.
The condition may still be possible after vaccination, recent studies have shown – although the risk of long-term covid is much lower for vaccinated people who experience a successful case.
The NIH effort to study the condition — called the Recover Initiative — has received $1.15 billion in funding from Congress over four years through a US rescue plan.
After months of limited news about the RECOVER initiative, the NIH announced Wednesday that it has been awarded nearly $470 million in a research grant to study longer-term COVID-19.
“We know that some people have had their lives completely overshadowed by the major long-term effects of COVID-19,” Collins said.
‘The aim of these studies will be to determine the cause and find the much needed answers to prevent this often debilitating condition and to help those who move on to recovery.’
The NIH announced that the massive award went to NYU Langone Medical Center, which will give smaller grants of $470 million to more than 100 researchers at more than 30 institutions.
These institutions intend to leverage the existing long COVID research efforts and recruit new patients into the study group, which consists of tens of thousands.
Long-term Covid patients experience a wide range of symptoms, from fatigue and fever to muscle aches, diarrhea and allergic reactions, a patient survey has found.
The scientists plan to collect a wealth of data on the RECOVER cohort. This includes analysis of clinical information, laboratory tests and recovery stages of patients.
Gary Gibbons said, “This scientifically rigorous approach establishes a collaborative and multidisciplinary research community involving diverse research participants who are critical to informing treatment and prevention of the long-term effects of COVID-19. ” Chairman of the RECOVER Initiative.
In developing the RECOVER Initiative’s protocol, the NIH worked with researchers who have already been studying COVID for a long time as well as the patients themselves.
patient groups such as body politic Scientists have long advocated for involving different groups of COVID patients in their research – including those who were not hospitalized or received positive test results.
Many long-term COVID patients who became infected early in the pandemic, unable to get tested due to limited testing supplies and other accessibility issues, were excluded from some later studies.
The RECOVER initiative aims to engage different groups of adults, children, pregnant people and patients at different stages of their COVID infection.
Patients who wish to volunteer for the initiative can sign up on the NIH website, recovercovid.org.
Many chronic covid patients experience symptoms for seven months or more
The NIH initiative aims to standardize clinical trial designs, ensuring that researchers from different institutions analyze data in the same way.
Researchers will use electronic health records as well as mobile health technology, such as smartphone apps and wearable devices, to track patients.
Through the initiative, NIH scientists aim to determine what exactly causes longer COVID-19 – a question that remains to be definitively answered.
‘Is it the misfiring of the immune system that fails to reset after infection with this coronavirus? Is it a trigger of metabolic dysfunction? We don’t know,’ Collins said in a media briefing on Wednesday.
‘The diversity of symptoms and presentations leads us to believe that long-term covid is not the only condition.
‘So, the only way we can solve this is with very large studies that collect a lot of data about symptoms, physical findings and laboratory …